OPGN
CapForce Inc.
Key Financials
Revenue
$30.2M
↑ 481.2%
Operating Income
$24.0M
↑ 7299.7%
Gross Profit
$924379
N/A
EPS (Diluted)
$2.32
↑ 0.9%
Net Income
$23.6M
↑ 97.0%
Total Liabilities
$6.2M
↑ 149.7%
Total Assets
$38.1M
↑ 285.8%
Shareholders' Equity
$31.9M
↑ 331.6%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| 10-Q | 6/12/2026 | View on SEC |
| 10-K | 5/26/2026 | View on SEC |
| NT 10-Q | 5/15/2026 | View on SEC |
| NT 10-K | 3/31/2026 | View on SEC |
| 8-K | 2/27/2026 | View on SEC |
| DEF 14A | 2/6/2026 | View on SEC |
| PRE 14A | 1/26/2026 | View on SEC |
| 8-K | 1/16/2026 | View on SEC |
| 8-K | 12/23/2025 | View on SEC |
| 3 | 12/10/2025 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | OPGN |
| Company Name | CapForce Inc. |
| CIK | 1293818 |
| Sector | Services-Medical Laboratories |
| Industry | Non-accelerated filer Smaller reporting company |
| SIC Code | 8071 |
| SIC Description | Services-Medical Laboratories |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | DE |
| Phone | 301-869-9683 |